ONX

Ovarian Adnexal Mass Assessment Score Test System

Product code
ONX
Device name
Ovarian Adnexal Mass Assessment Score Test System
Device class
Class 2
21 CFR
21 CFR 866.6050
Medical specialty
Obstetrics/Gynecology
Marketing pathway
510(K)
Flag
Third-party review eligible
510(k) clearances (all years, FDA)
6 (all years; only the last 3 years are listed here)

FDA classification definition

An ovarian/adnexal mass assessment test is a devicem that measures one or more proteins in serum. It yields a single result for the likelihood that an adnexal pelvic mass in a woman, for whom surgery is planned, is malignant. The test isn for adjunctive use, in teh context of a negative primary clinical and radiological evaluation, to augmrent the identification of patienets whose gynecologic surgery requires oncology expertise and resources.

Definition text from the FDA device classification database (U.S. federal government work, public domain).

Official FDA classification page: ONX
Classification and pathway per current FDA publications. Data from openFDA (CC0).